Ticker
ZLD
Analysis
Zelira Therapeutics Ltd. (ZLD) Stock Analysis
Zelira Therapeutics Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ZLD.
Zelira Therapeutics Ltd.
Zelira Therapeutics Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ZLD.
Stock profile
Asset type
Stock
Market cap
$4.2M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Currency
AUD
Ticker listings
Zelira Therapeutics Ltd. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- ZLD primary listing
- ZLDAF
- A2AS5H
- G1G
Latest Zelira Therapeutics Ltd. news
Suspension from Quotation
Suspension from Quotation
Quarterly Activities/Appendix 4C Cash Flow Report
Quarterly Activities/Appendix 4C Cash Flow Report
Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
Preliminary Final Report
Preliminary Final Report
Research sections
Valuation
Review valuation context for Zelira Therapeutics Ltd..
Future growth
Review future growth context for Zelira Therapeutics Ltd..
Past performance
Review past performance context for Zelira Therapeutics Ltd..
Financial health
Review financial health context for Zelira Therapeutics Ltd..
Dividend
Review dividend context for Zelira Therapeutics Ltd..
Management
Review management context for Zelira Therapeutics Ltd..
Ownership
Review ownership context for Zelira Therapeutics Ltd..
Other information
Review other information context for Zelira Therapeutics Ltd..
Community
Review community context for Zelira Therapeutics Ltd..